SteadySharesSteadyShares
The market
MarketsDiscover
Follow the money
Smart MoneyPolitician TradesCrypto Desk
Yours
My WealthNews
Settings Sign in to save your work
Closed
SteadySharesMarketsDiscoverSmart MoneyMy WealthPoliticiansCryptoNews
/
Discover4578.T
HealthcareTokyoJPY

Otsuka Holdings

¥0012345678900123456789,001234567890012345678900123456789.0012345678900123456789+4.6%
52w low (est.) ¥9,319.71¥13,463.89 52w high (est.)
Peers
Market data
Market cap
¥5.88T
52-week range
¥6,511.00 – ¥11,910.00
Sector
Healthcare
Valuation
P/E ratio
16.3x
DCF fair value
¥23,787.07
Margin of safety
+115.1%
Forward P/E
21.5x
PEG ratio
1.04
Dividend yield
1.25%
Quality & efficiency
Moat score
74/100
Return on equity
12.9%
Profit margin
15.0%
Debt / equity
0.06
Growth & analysts
Revenue growth (YoY)
+8.2%
Analyst target
¥12,900.00
Target upside
+16.6%
Analysts covering
12

About Otsuka Holdings

Otsuka Holdings Co., Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. It develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, autoimmune space digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices. It also provides clinical testing, medical equipment and tools, food products, cosmetics, functional food products, chemical products, soft drinks, beverages, analytical and measurement equipment, nutritional products, vehicle headlight testers, synthetic resin molded products, paper products, quasi-drugs, household products, and packaging materials and electronic parts. In addition, it offers IT solutions; adhesive tapes; flaky titanate and compounds; infusion and clinical nutrition products; hydrazine; plant-based food products; reinsurance underwriting services; wine; stable isotopes; food supplements; software and services for management of mental healthcare systems; anticancer drugs; terracess; bio-pesticides; dietetic food products; spring and mineral water; and polyolefin foams. Further, it engages in the warehousing and transport, medical device operational management, shared service, environmental health management, and venture capital and incubation businesses; rental of medical devices and related products; purchase and sale of agricultural products; import and export trading business; tuberculosis research and development activities; rental of space and office businesses; manufacturing and development of xenotransplantation products; and processing and marketing of functional films, as well as planning, design, production, and construction of ceramic boards and arts, ceramic walls, reliefs, terracotta, ceramic OT and portraits, and ceramic sign boards; and operation of travel agency, and Hotel Ridge and California Table. The company was founded in 1921 and is headquartered in Chiyoda, Japan.

Valuation

ValueGrowthProfitHealthIncome60QUALITY
Overall Rating
74
Strong Buy
Strong Buy
Moat Score74
DCF Intrinsic Value
¥23,787.07+115.1% upside

Moat, DCF and rating computed by our valuation engine (ported from the original Python model).

Fundamentals

Market Cap
¥5.88T
P/E Ratio
16.3
Dividend Yield
1.25%
Revenue Growth
+8.2%
Profit Margin
15.0%
ROE
12.9%
Debt / Equity
0.06
Beta
-0.05
Momentum
vs Healthcare sector:P/E 16 vs 28 · cheaperMoat 74 vs 7Yield 1.25% vs 0.3%

Statistics

Similar Stocks · Healthcare

LLY73
$920.00+0.7%
AZN.L72
£105.20+0.6%
UNH71
$492.10+1.6%
JNJ70
$146.20-0.2%

Latest News · 4578.T